JP2004509953A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004509953A5 JP2004509953A5 JP2002531107A JP2002531107A JP2004509953A5 JP 2004509953 A5 JP2004509953 A5 JP 2004509953A5 JP 2002531107 A JP2002531107 A JP 2002531107A JP 2002531107 A JP2002531107 A JP 2002531107A JP 2004509953 A5 JP2004509953 A5 JP 2004509953A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- morpholin
- dichlorobenzyl
- urea
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 description 42
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 24
- 125000006512 3,4-dichlorobenzyl group Chemical group [H]C1=C(Cl)C(Cl)=C([H])C(=C1[H])C([H])([H])* 0.000 description 22
- 125000000217 alkyl group Chemical group 0.000 description 20
- 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 description 20
- 229910052739 hydrogen Inorganic materials 0.000 description 18
- 239000001257 hydrogen Substances 0.000 description 18
- -1 aryl-C2-6Alkenyl Chemical group 0.000 description 17
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 16
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 16
- 125000003118 aryl group Chemical group 0.000 description 11
- 239000012453 solvate Substances 0.000 description 11
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 10
- 229910052760 oxygen Inorganic materials 0.000 description 10
- 239000001301 oxygen Substances 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 239000011593 sulfur Substances 0.000 description 10
- 239000004202 carbamide Substances 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 229910052717 sulfur Inorganic materials 0.000 description 9
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 125000001072 heteroaryl group Chemical group 0.000 description 6
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 5
- 125000000753 cycloalkyl group Chemical group 0.000 description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 description 5
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 4
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 4
- 125000000392 cycloalkenyl group Chemical group 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 3
- HFKSPOZYFRZZBJ-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 HFKSPOZYFRZZBJ-UHFFFAOYSA-N 0.000 description 3
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 3
- 125000005843 halogen group Chemical group 0.000 description 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 2
- JZBGNRGEOVQVEE-LBPRGKRZSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(2-methyltetrazol-5-yl)methyl]urea Chemical compound CN1N=NC(CNC(=O)NC[C@@H]2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=N1 JZBGNRGEOVQVEE-LBPRGKRZSA-N 0.000 description 2
- RLGDJANJVUKARK-SFHVURJKSA-N 4-[[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1CNC(=O)NC[C@@H]1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 RLGDJANJVUKARK-SFHVURJKSA-N 0.000 description 2
- GPLUUMAKBFSDIE-KRWDZBQOSA-N 4-[[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1CNC(=O)NC[C@@H]1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 GPLUUMAKBFSDIE-KRWDZBQOSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical group C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- IJYMVDXPULPUGS-OWOJBTEDSA-N (E)-4-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]but-2-enoic acid Chemical compound C1COC(CNC(=O)NC/C=C/C(=O)O)CN1Cc1ccc(Cl)c(Cl)c1 IJYMVDXPULPUGS-OWOJBTEDSA-N 0.000 description 1
- OFASZEVOCQKUAG-UHFFFAOYSA-N 1,3-bis[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)OCC1 OFASZEVOCQKUAG-UHFFFAOYSA-N 0.000 description 1
- WVCDSELVRXKGKD-UHFFFAOYSA-N 1-(1-benzoylpiperidin-4-yl)-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC2CCN(CC2)C(=O)C=2C=CC=CC=2)OCC1 WVCDSELVRXKGKD-UHFFFAOYSA-N 0.000 description 1
- QZYUSYJXVMRQNM-UHFFFAOYSA-N 1-(3-bromophenyl)-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC=2C=C(Br)C=CC=2)OCC1 QZYUSYJXVMRQNM-UHFFFAOYSA-N 0.000 description 1
- CETNYFPESALINJ-UHFFFAOYSA-N 1-(3-chlorophenyl)-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound ClC1=CC=CC(NC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 CETNYFPESALINJ-UHFFFAOYSA-N 0.000 description 1
- GEKMNZWPOKHNJK-UHFFFAOYSA-N 1-(3-cyanophenyl)-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC=2C=C(C=CC=2)C#N)OCC1 GEKMNZWPOKHNJK-UHFFFAOYSA-N 0.000 description 1
- QIKALZSPXCSEAT-INIZCTEOSA-N 1-(3-tert-butylsulfonylpropyl)-3-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1CO[C@@H](CNC(=O)NCCCS(=O)(=O)C(C)(C)C)CN1CC1=CC=C(Cl)C(Cl)=C1 QIKALZSPXCSEAT-INIZCTEOSA-N 0.000 description 1
- MKBLQSFKFNDVLX-UHFFFAOYSA-N 1-(4-bromophenyl)-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC=2C=CC(Br)=CC=2)OCC1 MKBLQSFKFNDVLX-UHFFFAOYSA-N 0.000 description 1
- CUEKMUYPOKHPEE-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-(2-methoxyethyl)morpholin-2-yl]methyl]urea Chemical compound C1N(CCOC)CCOC1CNC(=O)NC1=CC=C(Cl)C=C1 CUEKMUYPOKHPEE-UHFFFAOYSA-N 0.000 description 1
- DNEKWVAUXSDQFQ-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-(2-phenylsulfanylethyl)morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CCSC=2C=CC=CC=2)C1 DNEKWVAUXSDQFQ-UHFFFAOYSA-N 0.000 description 1
- MZOYOSRKYQNISE-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-(3,4-dichlorobenzoyl)morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(C(=O)C=2C=C(Cl)C(Cl)=CC=2)C1 MZOYOSRKYQNISE-UHFFFAOYSA-N 0.000 description 1
- GXCPRHGMOJUQCQ-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-(cyanomethyl)morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CC#N)C1 GXCPRHGMOJUQCQ-UHFFFAOYSA-N 0.000 description 1
- RKDCDFYJHFQLBQ-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-(naphthalen-1-ylmethyl)morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CC=2C3=CC=CC=C3C=CC=2)C1 RKDCDFYJHFQLBQ-UHFFFAOYSA-N 0.000 description 1
- VOVMLQSVJMKLEN-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-(naphthalen-2-ylmethyl)morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CC=2C=C3C=CC=CC3=CC=2)C1 VOVMLQSVJMKLEN-UHFFFAOYSA-N 0.000 description 1
- UWRSYIYMRLWCPN-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-[(3-chlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(Cl)C=CC=2)C1 UWRSYIYMRLWCPN-UHFFFAOYSA-N 0.000 description 1
- ZEEVVNROOCMRQZ-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-[(3-iodophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(I)C=CC=2)C1 ZEEVVNROOCMRQZ-UHFFFAOYSA-N 0.000 description 1
- CIKUSCIEGFQUJK-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-[(4-ethenylphenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CC=2C=CC(C=C)=CC=2)C1 CIKUSCIEGFQUJK-UHFFFAOYSA-N 0.000 description 1
- HPAOEQJGXJKTTP-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-[(4-phenylphenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CC=2C=CC(=CC=2)C=2C=CC=CC=2)C1 HPAOEQJGXJKTTP-UHFFFAOYSA-N 0.000 description 1
- NSVOKHWMZIYXRT-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-[(5-chlorothiophen-2-yl)methyl]morpholin-2-yl]methyl]urea Chemical compound S1C(Cl)=CC=C1CN1CC(CNC(=O)NC=2C=CC(Cl)=CC=2)OCC1 NSVOKHWMZIYXRT-UHFFFAOYSA-N 0.000 description 1
- MNTQHEQUOPXTHV-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[[4-[2-(4-fluorophenoxy)ethyl]morpholin-2-yl]methyl]urea Chemical compound C1=CC(F)=CC=C1OCCN1CC(CNC(=O)NC=2C=CC(Cl)=CC=2)OCC1 MNTQHEQUOPXTHV-UHFFFAOYSA-N 0.000 description 1
- JSFRQVBURHCSRQ-UHFFFAOYSA-N 1-(4-cyanophenyl)-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC=2C=CC(=CC=2)C#N)OCC1 JSFRQVBURHCSRQ-UHFFFAOYSA-N 0.000 description 1
- KDWWACJTGVYXJA-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC=2C(=CC=CC=2)Cl)OCC1 KDWWACJTGVYXJA-UHFFFAOYSA-N 0.000 description 1
- LNLSTUJGFCXOQC-UHFFFAOYSA-N 1-[(3,5-dichlorophenyl)methyl]-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound ClC1=CC(Cl)=CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 LNLSTUJGFCXOQC-UHFFFAOYSA-N 0.000 description 1
- ORWBPAROFHCSAZ-UHFFFAOYSA-N 1-[(3-chlorophenyl)methyl]-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound ClC1=CC=CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 ORWBPAROFHCSAZ-UHFFFAOYSA-N 0.000 description 1
- NXWWILBKOCCPEA-UHFFFAOYSA-N 1-[(3-cyanophenyl)methyl]-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC=2C=C(C=CC=2)C#N)OCC1 NXWWILBKOCCPEA-UHFFFAOYSA-N 0.000 description 1
- XFOKYSOGMLELDG-UHFFFAOYSA-N 1-[(4-but-3-enylmorpholin-2-yl)methyl]-3-(4-chlorophenyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CCC=C)C1 XFOKYSOGMLELDG-UHFFFAOYSA-N 0.000 description 1
- SIGUZGFURPEAFO-UHFFFAOYSA-N 1-[(4-chlorophenyl)methyl]-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 SIGUZGFURPEAFO-UHFFFAOYSA-N 0.000 description 1
- KKDZSEQGEKNRQW-UHFFFAOYSA-N 1-[(4-cyanophenyl)methyl]-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC=2C=CC(=CC=2)C#N)OCC1 KKDZSEQGEKNRQW-UHFFFAOYSA-N 0.000 description 1
- XLUKYSBCGPFVOU-UHFFFAOYSA-N 1-[(5-amino-1-phenylpyrazol-4-yl)methyl]-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=NN(C=2C=CC=CC=2)C(N)=C1CNC(=O)NCC(OCC1)CN1CC1=CC=C(Cl)C(Cl)=C1 XLUKYSBCGPFVOU-UHFFFAOYSA-N 0.000 description 1
- WXFNYPNDMNETIN-UHFFFAOYSA-N 1-[3-(benzenesulfonyl)propyl]-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCCCS(=O)(=O)C=2C=CC=CC=2)OCC1 WXFNYPNDMNETIN-UHFFFAOYSA-N 0.000 description 1
- ZMLBFPWNXWIJCP-CYBMUJFWSA-N 1-[[(2r)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-prop-2-ynylurea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1C[C@@H](CNC(=O)NCC#C)OCC1 ZMLBFPWNXWIJCP-CYBMUJFWSA-N 0.000 description 1
- LAHSCJWLPCJWQW-ZDUSSCGKSA-N 1-[[(2s)-4-[(2,3-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-prop-2-ynylurea Chemical compound ClC1=CC=CC(CN2C[C@H](CNC(=O)NCC#C)OCC2)=C1Cl LAHSCJWLPCJWQW-ZDUSSCGKSA-N 0.000 description 1
- CHFLRXHBQCODJY-ZDUSSCGKSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(1,3-thiazol-2-ylmethyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1C[C@H](CNC(=O)NCC=2SC=CN=2)OCC1 CHFLRXHBQCODJY-ZDUSSCGKSA-N 0.000 description 1
- IIDLTYKRGNHTEA-SFHVURJKSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(2-phenoxyethyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1C[C@H](CNC(=O)NCCOC=2C=CC=CC=2)OCC1 IIDLTYKRGNHTEA-SFHVURJKSA-N 0.000 description 1
- QZYFSWGSMHRMHM-HNNXBMFYSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(3-ethylsulfonylpropyl)urea Chemical compound C1CO[C@@H](CNC(=O)NCCCS(=O)(=O)CC)CN1CC1=CC=C(Cl)C(Cl)=C1 QZYFSWGSMHRMHM-HNNXBMFYSA-N 0.000 description 1
- VMIHJDOWTRWMEG-INIZCTEOSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(3-propan-2-ylsulfonylpropyl)urea Chemical compound C1CO[C@@H](CNC(=O)NCCCS(=O)(=O)C(C)C)CN1CC1=CC=C(Cl)C(Cl)=C1 VMIHJDOWTRWMEG-INIZCTEOSA-N 0.000 description 1
- CEIGWVODZRCVMH-INIZCTEOSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(3-propylsulfonylpropyl)urea Chemical compound C1CO[C@@H](CNC(=O)NCCCS(=O)(=O)CCC)CN1CC1=CC=C(Cl)C(Cl)=C1 CEIGWVODZRCVMH-INIZCTEOSA-N 0.000 description 1
- FXOLBPVVGGAMSU-KRWDZBQOSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(3-pyrrolidin-1-ylsulfonylpropyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1C[C@H](CNC(=O)NCCCS(=O)(=O)N2CCCC2)OCC1 FXOLBPVVGGAMSU-KRWDZBQOSA-N 0.000 description 1
- PCMVUEJROCBCFO-KRWDZBQOSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(1-methylsulfonylpiperidin-4-yl)methyl]urea Chemical compound C1CN(S(=O)(=O)C)CCC1CNC(=O)NC[C@@H]1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 PCMVUEJROCBCFO-KRWDZBQOSA-N 0.000 description 1
- ICBCSZQUXHMHIO-SFHVURJKSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(4-methoxyphenyl)methyl]urea Chemical compound C1=CC(OC)=CC=C1CNC(=O)NC[C@@H]1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 ICBCSZQUXHMHIO-SFHVURJKSA-N 0.000 description 1
- SOANXCFVMUFQHE-AWEZNQCLSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(4-methyl-1,3-thiazol-2-yl)methyl]urea Chemical compound CC1=CSC(CNC(=O)NC[C@@H]2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=N1 SOANXCFVMUFQHE-AWEZNQCLSA-N 0.000 description 1
- ODWDLPNSSPJZKN-SFHVURJKSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[2-(4-methoxyphenyl)-2-oxoethyl]urea Chemical compound C1=CC(OC)=CC=C1C(=O)CNC(=O)NC[C@@H]1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 ODWDLPNSSPJZKN-SFHVURJKSA-N 0.000 description 1
- DKUHRBJUMSGGJZ-AWEZNQCLSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[3-(methylsulfamoyl)propyl]urea Chemical compound C1CO[C@@H](CNC(=O)NCCCS(=O)(=O)NC)CN1CC1=CC=C(Cl)C(Cl)=C1 DKUHRBJUMSGGJZ-AWEZNQCLSA-N 0.000 description 1
- OUTJFGNYCUCTLX-INIZCTEOSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-phenoxyurea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1C[C@H](CNC(=O)NOC=2C=CC=CC=2)OCC1 OUTJFGNYCUCTLX-INIZCTEOSA-N 0.000 description 1
- ZMLBFPWNXWIJCP-ZDUSSCGKSA-N 1-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-prop-2-ynylurea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1C[C@H](CNC(=O)NCC#C)OCC1 ZMLBFPWNXWIJCP-ZDUSSCGKSA-N 0.000 description 1
- RWZSUMWZLNZXGU-HNNXBMFYSA-N 1-[[(2s)-4-[(3-chlorophenyl)methyl]morpholin-2-yl]methyl]-3-prop-2-ynylurea Chemical compound ClC1=CC=CC(CN2C[C@H](CNC(=O)NCC#C)OCC2)=C1 RWZSUMWZLNZXGU-HNNXBMFYSA-N 0.000 description 1
- UOICCPLYMXRJRW-NSHDSACASA-N 1-[[(2s)-4-[(5-chlorothiophen-2-yl)methyl]morpholin-2-yl]methyl]-3-prop-2-ynylurea Chemical compound S1C(Cl)=CC=C1CN1C[C@H](CNC(=O)NCC#C)OCC1 UOICCPLYMXRJRW-NSHDSACASA-N 0.000 description 1
- IVDLZDAZTCGYPL-IBGZPJMESA-N 1-[[1-(cyclopropanecarbonyl)piperidin-4-yl]methyl]-3-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1C[C@H](CNC(=O)NCC2CCN(CC2)C(=O)C2CC2)OCC1 IVDLZDAZTCGYPL-IBGZPJMESA-N 0.000 description 1
- KMAFRTKBDGSAJJ-IBGZPJMESA-N 1-[[3-(4-chlorophenyl)-1,2-oxazol-5-yl]methyl]-3-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=CC(Cl)=CC=C1C1=NOC(CNC(=O)NC[C@@H]2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 KMAFRTKBDGSAJJ-IBGZPJMESA-N 0.000 description 1
- CHFLRXHBQCODJY-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(1,3-thiazol-2-ylmethyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC=2SC=CN=2)OCC1 CHFLRXHBQCODJY-UHFFFAOYSA-N 0.000 description 1
- MDWXKLOKONVIFC-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(1-methylsulfonylpiperidin-4-yl)urea Chemical compound C1CN(S(=O)(=O)C)CCC1NC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 MDWXKLOKONVIFC-UHFFFAOYSA-N 0.000 description 1
- LJQCWQGMVJGSKQ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(1h-indol-4-ylmethyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC=2C=3C=CNC=3C=CC=2)OCC1 LJQCWQGMVJGSKQ-UHFFFAOYSA-N 0.000 description 1
- YSSDLSCDXACWQT-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(1h-indol-5-ylmethyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC=2C=C3C=CNC3=CC=2)OCC1 YSSDLSCDXACWQT-UHFFFAOYSA-N 0.000 description 1
- ORWIEFDDVAPGJN-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(2,3-dihydro-1-benzofuran-5-ylmethyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC=2C=C3CCOC3=CC=2)OCC1 ORWIEFDDVAPGJN-UHFFFAOYSA-N 0.000 description 1
- LFQKNPBHEVMIQQ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(2,6-dichloropyridin-4-yl)urea Chemical compound ClC1=NC(Cl)=CC(NC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 LFQKNPBHEVMIQQ-UHFFFAOYSA-N 0.000 description 1
- AXSLIQAVZBTCCU-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(2-morpholin-4-ylethyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCCN2CCOCC2)OCC1 AXSLIQAVZBTCCU-UHFFFAOYSA-N 0.000 description 1
- DKGKGYIRSBFUAB-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(2-phenylethyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCCC=2C=CC=CC=2)OCC1 DKGKGYIRSBFUAB-UHFFFAOYSA-N 0.000 description 1
- TXGLHHRLOVQCHU-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(2-phenylpropan-2-yl)urea Chemical compound C=1C=CC=CC=1C(C)(C)NC(=O)NCC(OCC1)CN1CC1=CC=C(Cl)C(Cl)=C1 TXGLHHRLOVQCHU-UHFFFAOYSA-N 0.000 description 1
- CXVSJGGLVSFXEX-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(2-pyrrolidin-1-ylsulfonylethyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCCS(=O)(=O)N2CCCC2)OCC1 CXVSJGGLVSFXEX-UHFFFAOYSA-N 0.000 description 1
- YESMWHHSKLCUDO-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(2-thiophen-2-ylethyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCCC=2SC=CC=2)OCC1 YESMWHHSKLCUDO-UHFFFAOYSA-N 0.000 description 1
- UHYMDBFNUWROLZ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(3-fluorophenyl)urea Chemical compound FC1=CC=CC(NC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 UHYMDBFNUWROLZ-UHFFFAOYSA-N 0.000 description 1
- OPYYDXYTYFFBBW-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(3-methylsulfanylphenyl)urea Chemical compound CSC1=CC=CC(NC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 OPYYDXYTYFFBBW-UHFFFAOYSA-N 0.000 description 1
- DEMYSZUWDGRNGM-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(4-fluorophenyl)urea Chemical compound C1=CC(F)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 DEMYSZUWDGRNGM-UHFFFAOYSA-N 0.000 description 1
- BIHGLLSUXLBXLU-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(4-hydroxybut-2-ynyl)urea Chemical compound C1COC(CNC(=O)NCC#CCO)CN1CC1=CC=C(Cl)C(Cl)=C1 BIHGLLSUXLBXLU-UHFFFAOYSA-N 0.000 description 1
- PUUWAZJAOMWEIH-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(4-phenoxyphenyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC=2C=CC(OC=3C=CC=CC=3)=CC=2)OCC1 PUUWAZJAOMWEIH-UHFFFAOYSA-N 0.000 description 1
- INNSYWQLCUKLPA-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(4-phenylphenyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC=2C=CC(=CC=2)C=2C=CC=CC=2)OCC1 INNSYWQLCUKLPA-UHFFFAOYSA-N 0.000 description 1
- UBRNPKULFLNKTN-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(furan-2-ylmethyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC=2OC=CC=2)OCC1 UBRNPKULFLNKTN-UHFFFAOYSA-N 0.000 description 1
- XNCBQNKFSGAXTG-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(oxan-4-yl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC2CCOCC2)OCC1 XNCBQNKFSGAXTG-UHFFFAOYSA-N 0.000 description 1
- RSFBEASASGMROQ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(pyrazin-2-ylmethyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC=2N=CC=NC=2)OCC1 RSFBEASASGMROQ-UHFFFAOYSA-N 0.000 description 1
- JOAMKEZJIZMCCP-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(pyridin-3-ylmethyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC=2C=NC=CC=2)OCC1 JOAMKEZJIZMCCP-UHFFFAOYSA-N 0.000 description 1
- VZGWAOAOOYPEKX-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(thian-4-yl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC2CCSCC2)OCC1 VZGWAOAOOYPEKX-UHFFFAOYSA-N 0.000 description 1
- PMMVLXWWCMYNLR-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-(thiophen-2-ylmethyl)urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC=2SC=CC=2)OCC1 PMMVLXWWCMYNLR-UHFFFAOYSA-N 0.000 description 1
- MVRPDZUVRGRUCB-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(2,4-difluorophenyl)methyl]urea Chemical compound FC1=CC(F)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 MVRPDZUVRGRUCB-UHFFFAOYSA-N 0.000 description 1
- ZQRYURLXJSYCGR-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(2,4-dimethoxyphenyl)methyl]urea Chemical compound COC1=CC(OC)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 ZQRYURLXJSYCGR-UHFFFAOYSA-N 0.000 description 1
- NAMNZZPUSHWGBR-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(2-fluorophenyl)methyl]urea Chemical compound FC1=CC=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 NAMNZZPUSHWGBR-UHFFFAOYSA-N 0.000 description 1
- ZXAYMAJLQPFCEI-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(2-methyl-1,3-thiazol-4-yl)methyl]urea Chemical compound S1C(C)=NC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 ZXAYMAJLQPFCEI-UHFFFAOYSA-N 0.000 description 1
- WKOHCPXDTNECSH-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(2-methylphenyl)methyl]urea Chemical compound CC1=CC=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 WKOHCPXDTNECSH-UHFFFAOYSA-N 0.000 description 1
- RRQIDZNKMNYUCO-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(2-methylsulfanylphenyl)methyl]urea Chemical compound CSC1=CC=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 RRQIDZNKMNYUCO-UHFFFAOYSA-N 0.000 description 1
- JZBGNRGEOVQVEE-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(2-methyltetrazol-5-yl)methyl]urea Chemical compound CN1N=NC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=N1 JZBGNRGEOVQVEE-UHFFFAOYSA-N 0.000 description 1
- NFAVUCBRCJYPCZ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(3,4-difluorophenyl)methyl]urea Chemical compound C1=C(F)C(F)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 NFAVUCBRCJYPCZ-UHFFFAOYSA-N 0.000 description 1
- IYJQIZVQGGISOT-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(3,4-dimethoxyphenyl)methyl]urea Chemical compound C1=C(OC)C(OC)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 IYJQIZVQGGISOT-UHFFFAOYSA-N 0.000 description 1
- NAUCNUQFDQAGGQ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(3-fluorophenyl)methyl]urea Chemical compound FC1=CC=CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 NAUCNUQFDQAGGQ-UHFFFAOYSA-N 0.000 description 1
- ZALONBKTWCFUDD-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(3-methoxy-1,2-thiazol-5-yl)methyl]urea Chemical compound S1N=C(OC)C=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 ZALONBKTWCFUDD-UHFFFAOYSA-N 0.000 description 1
- IMSHBRNTISBKFA-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(3-methoxyphenyl)methyl]urea Chemical compound COC1=CC=CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 IMSHBRNTISBKFA-UHFFFAOYSA-N 0.000 description 1
- CRCIFIMKJNSOIV-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(3-methylphenyl)methyl]urea Chemical compound CC1=CC=CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 CRCIFIMKJNSOIV-UHFFFAOYSA-N 0.000 description 1
- WSBJFOIHSAQYAZ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(4-fluorophenyl)methyl]urea Chemical compound C1=CC(F)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 WSBJFOIHSAQYAZ-UHFFFAOYSA-N 0.000 description 1
- ICBCSZQUXHMHIO-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(4-methoxyphenyl)methyl]urea Chemical compound C1=CC(OC)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 ICBCSZQUXHMHIO-UHFFFAOYSA-N 0.000 description 1
- SOANXCFVMUFQHE-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(4-methyl-1,3-thiazol-2-yl)methyl]urea Chemical compound CC1=CSC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=N1 SOANXCFVMUFQHE-UHFFFAOYSA-N 0.000 description 1
- FVSRFSLJDIVEQC-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(4-methylphenyl)methyl]urea Chemical compound C1=CC(C)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 FVSRFSLJDIVEQC-UHFFFAOYSA-N 0.000 description 1
- ZYPZLUXGOVRXGE-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(4-methylsulfonylphenyl)methyl]urea Chemical compound C1=CC(S(=O)(=O)C)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 ZYPZLUXGOVRXGE-UHFFFAOYSA-N 0.000 description 1
- RRVHLDBPVAGXKE-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(4-propan-2-yloxyphenyl)methyl]urea Chemical compound C1=CC(OC(C)C)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 RRVHLDBPVAGXKE-UHFFFAOYSA-N 0.000 description 1
- KKDYVYFNQWWRRG-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(5-methyl-1,2-oxazol-3-yl)methyl]urea Chemical compound O1C(C)=CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=N1 KKDYVYFNQWWRRG-UHFFFAOYSA-N 0.000 description 1
- PONVDQFSFUCTIN-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[(6-methoxypyridin-3-yl)methyl]urea Chemical compound C1=NC(OC)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 PONVDQFSFUCTIN-UHFFFAOYSA-N 0.000 description 1
- XSJMHPTXXUWOMU-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[1-(4-fluorophenyl)ethyl]urea Chemical compound C=1C=C(F)C=CC=1C(C)NC(=O)NCC(OCC1)CN1CC1=CC=C(Cl)C(Cl)=C1 XSJMHPTXXUWOMU-UHFFFAOYSA-N 0.000 description 1
- AMOYULQCQDEMTJ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[1-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonyl]piperidin-4-yl]urea Chemical compound CC1=NOC(C)=C1S(=O)(=O)N1CCC(NC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)CC1 AMOYULQCQDEMTJ-UHFFFAOYSA-N 0.000 description 1
- AEAIUCKNFHHLQW-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[2-(2-oxoimidazolidin-1-yl)ethyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCCN2C(NCC2)=O)OCC1 AEAIUCKNFHHLQW-UHFFFAOYSA-N 0.000 description 1
- UCLNLRJCWBZNAQ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[2-(4-methoxyphenyl)ethyl]urea Chemical compound C1=CC(OC)=CC=C1CCNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 UCLNLRJCWBZNAQ-UHFFFAOYSA-N 0.000 description 1
- JWPPXEJEJMUXMV-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[2-(methanesulfonamido)ethyl]urea Chemical compound C1COC(CNC(=O)NCCNS(=O)(=O)C)CN1CC1=CC=C(Cl)C(Cl)=C1 JWPPXEJEJMUXMV-UHFFFAOYSA-N 0.000 description 1
- KIAZDICJZPPPJD-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[2-[4-[(2-methylpropan-2-yl)oxy]phenyl]ethyl]urea Chemical compound C1=CC(OC(C)(C)C)=CC=C1CCNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 KIAZDICJZPPPJD-UHFFFAOYSA-N 0.000 description 1
- GXYOVBYXBLYSPG-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[4-(difluoromethoxy)phenyl]urea Chemical compound C1=CC(OC(F)F)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 GXYOVBYXBLYSPG-UHFFFAOYSA-N 0.000 description 1
- FLMNVALQNMHKEJ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[4-(dimethylamino)phenyl]urea Chemical compound C1=CC(N(C)C)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 FLMNVALQNMHKEJ-UHFFFAOYSA-N 0.000 description 1
- XKRCHAWYLMZVQM-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[4-(trifluoromethoxy)phenyl]urea Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 XKRCHAWYLMZVQM-UHFFFAOYSA-N 0.000 description 1
- XDVYKNRJEWXJIF-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[4-(trifluoromethylsulfanyl)phenyl]urea Chemical compound C1=CC(SC(F)(F)F)=CC=C1NC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 XDVYKNRJEWXJIF-UHFFFAOYSA-N 0.000 description 1
- HXYDGJYUGNLHTP-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[[2-(trifluoromethoxy)phenyl]methyl]urea Chemical compound FC(F)(F)OC1=CC=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 HXYDGJYUGNLHTP-UHFFFAOYSA-N 0.000 description 1
- HFAJLYADOJWONP-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[[2-(trifluoromethyl)phenyl]methyl]urea Chemical compound FC(F)(F)C1=CC=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 HFAJLYADOJWONP-UHFFFAOYSA-N 0.000 description 1
- DFPVRXBHKCCUJQ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[[3-(dimethylamino)phenyl]methyl]urea Chemical compound CN(C)C1=CC=CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 DFPVRXBHKCCUJQ-UHFFFAOYSA-N 0.000 description 1
- DJHGDZFTZUVAMK-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[[3-(trifluoromethoxy)phenyl]methyl]urea Chemical compound FC(F)(F)OC1=CC=CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 DJHGDZFTZUVAMK-UHFFFAOYSA-N 0.000 description 1
- PZRXDQFNHMGXOH-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[[3-(trifluoromethyl)phenyl]methyl]urea Chemical compound FC(F)(F)C1=CC=CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 PZRXDQFNHMGXOH-UHFFFAOYSA-N 0.000 description 1
- LEDYMWYAHIXNJZ-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[[4-(thiadiazol-4-yl)phenyl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC=2C=CC(=CC=2)C=2N=NSC=2)OCC1 LEDYMWYAHIXNJZ-UHFFFAOYSA-N 0.000 description 1
- PDHGQIHGFFGVOP-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[[4-(trifluoromethoxy)phenyl]methyl]urea Chemical compound C1=CC(OC(F)(F)F)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 PDHGQIHGFFGVOP-UHFFFAOYSA-N 0.000 description 1
- HTXCODFREIEENI-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[[4-(trifluoromethyl)phenyl]methyl]urea Chemical compound C1=CC(C(F)(F)F)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 HTXCODFREIEENI-UHFFFAOYSA-N 0.000 description 1
- WQNPBIUZGHSLPX-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[[5-[(dimethylamino)methyl]furan-2-yl]methyl]urea Chemical compound O1C(CN(C)C)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 WQNPBIUZGHSLPX-UHFFFAOYSA-N 0.000 description 1
- NYLJYXFMJQIKII-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-[[5-[(dimethylamino)methyl]thiophen-2-yl]methyl]urea Chemical compound S1C(CN(C)C)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 NYLJYXFMJQIKII-UHFFFAOYSA-N 0.000 description 1
- ZMLBFPWNXWIJCP-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-prop-2-ynylurea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC#C)OCC1 ZMLBFPWNXWIJCP-UHFFFAOYSA-N 0.000 description 1
- IEXATMDXWVMVMV-UHFFFAOYSA-N 1-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-3-propylurea Chemical compound C1COC(CNC(=O)NCCC)CN1CC1=CC=C(Cl)C(Cl)=C1 IEXATMDXWVMVMV-UHFFFAOYSA-N 0.000 description 1
- YERNFDKVUFSFOB-UHFFFAOYSA-N 1-[[4-[2-(2,3-dihydroindol-1-yl)-2-oxoethyl]morpholin-2-yl]methyl]-3-phenylurea Chemical compound C1N(CC(=O)N2C3=CC=CC=C3CC2)CCOC1CNC(=O)NC1=CC=CC=C1 YERNFDKVUFSFOB-UHFFFAOYSA-N 0.000 description 1
- WFPBIRCLKDQKIZ-MAUKXSAKSA-N 1-benzyl-3-[[(2r,5s)-4-[(3,4-dichlorophenyl)methyl]-5-methylmorpholin-2-yl]methyl]urea Chemical compound C([C@H]1OC[C@@H](N(C1)CC=1C=C(Cl)C(Cl)=CC=1)C)NC(=O)NCC1=CC=CC=C1 WFPBIRCLKDQKIZ-MAUKXSAKSA-N 0.000 description 1
- WFPBIRCLKDQKIZ-QAPCUYQASA-N 1-benzyl-3-[[(2s,5r)-4-[(3,4-dichlorophenyl)methyl]-5-methylmorpholin-2-yl]methyl]urea Chemical compound C([C@@H]1OC[C@H](N(C1)CC=1C=C(Cl)C(Cl)=CC=1)C)NC(=O)NCC1=CC=CC=C1 WFPBIRCLKDQKIZ-QAPCUYQASA-N 0.000 description 1
- SJJRCWDWUXSGPZ-UHFFFAOYSA-N 1-benzyl-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCC=2C=CC=CC=2)OCC1 SJJRCWDWUXSGPZ-UHFFFAOYSA-N 0.000 description 1
- PFPGCOHVSVVMAC-UHFFFAOYSA-N 1-but-3-enyl-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCCC=C)OCC1 PFPGCOHVSVVMAC-UHFFFAOYSA-N 0.000 description 1
- RGBQGGXEXVDDJA-UHFFFAOYSA-N 1-but-3-ynyl-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NCCC#C)OCC1 RGBQGGXEXVDDJA-UHFFFAOYSA-N 0.000 description 1
- DEIWIHSUCRYIQL-UHFFFAOYSA-N 1-cyclohexyl-3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]urea Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)NC2CCCCC2)OCC1 DEIWIHSUCRYIQL-UHFFFAOYSA-N 0.000 description 1
- CKKBZPYNZHWHIL-UHFFFAOYSA-N 2-[2-[[(4-chlorophenyl)carbamoylamino]methyl]morpholin-4-yl]-2-phenylacetamide Chemical compound C=1C=CC=CC=1C(C(=O)N)N(C1)CCOC1CNC(=O)NC1=CC=C(Cl)C=C1 CKKBZPYNZHWHIL-UHFFFAOYSA-N 0.000 description 1
- YDZJZEURNNYQTQ-UHFFFAOYSA-N 2-[2-[[(4-chlorophenyl)carbamoylamino]methyl]morpholin-4-yl]ethyl benzoate Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCC1OCCN(CCOC(=O)C=2C=CC=CC=2)C1 YDZJZEURNNYQTQ-UHFFFAOYSA-N 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
- SPOVEJAPXRPMBI-UHFFFAOYSA-N 3-[3-(trifluoromethyl)phenyl]-1-methylurea Chemical compound CNC(=O)NC1=CC=CC(C(F)(F)F)=C1 SPOVEJAPXRPMBI-UHFFFAOYSA-N 0.000 description 1
- ILTNJCMRAZYCNS-UHFFFAOYSA-N 3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-1-(3-hydroxypropyl)-1-pyridin-2-ylurea Chemical compound C=1C=CC=NC=1N(CCCO)C(=O)NCC(OCC1)CN1CC1=CC=C(Cl)C(Cl)=C1 ILTNJCMRAZYCNS-UHFFFAOYSA-N 0.000 description 1
- RCZUDENHCBDSJA-UHFFFAOYSA-N 3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-1-(4-fluorophenyl)-1-methylurea Chemical compound C=1C=C(F)C=CC=1N(C)C(=O)NCC(OCC1)CN1CC1=CC=C(Cl)C(Cl)=C1 RCZUDENHCBDSJA-UHFFFAOYSA-N 0.000 description 1
- RMQKFOOLNRWRDW-UHFFFAOYSA-N 3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-1-[(4-methoxyphenyl)methyl]-1-methylurea Chemical compound C1=CC(OC)=CC=C1CN(C)C(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 RMQKFOOLNRWRDW-UHFFFAOYSA-N 0.000 description 1
- NDPLWIUMOIDORW-UHFFFAOYSA-N 3-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-1-methyl-1-pyridin-4-ylurea Chemical compound C=1C=NC=CC=1N(C)C(=O)NCC(OCC1)CN1CC1=CC=C(Cl)C(Cl)=C1 NDPLWIUMOIDORW-UHFFFAOYSA-N 0.000 description 1
- CGWLJFUYSGUJJN-SFHVURJKSA-N 3-[[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]-n-methylbenzamide Chemical compound CNC(=O)C1=CC=CC(CNC(=O)NC[C@@H]2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 CGWLJFUYSGUJJN-SFHVURJKSA-N 0.000 description 1
- XGVFMRQMYNBEEH-UHFFFAOYSA-N 3-[[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]-n,n-dimethylbenzamide Chemical compound CN(C)C(=O)C1=CC=CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 XGVFMRQMYNBEEH-UHFFFAOYSA-N 0.000 description 1
- LVBWNCGBKNOVQX-UHFFFAOYSA-N 3-[[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]-n-ethylbenzamide Chemical compound CCNC(=O)C1=CC=CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 LVBWNCGBKNOVQX-UHFFFAOYSA-N 0.000 description 1
- CGWLJFUYSGUJJN-UHFFFAOYSA-N 3-[[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]-n-methylbenzamide Chemical compound CNC(=O)C1=CC=CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 CGWLJFUYSGUJJN-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- RZPJSRWGLWNLTJ-AWEZNQCLSA-N 4-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]-n-methylbutanamide Chemical compound C1CO[C@@H](CNC(=O)NCCCC(=O)NC)CN1CC1=CC=C(Cl)C(Cl)=C1 RZPJSRWGLWNLTJ-AWEZNQCLSA-N 0.000 description 1
- GPLUUMAKBFSDIE-QGZVFWFLSA-N 4-[[[(2r)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1CNC(=O)NC[C@H]1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 GPLUUMAKBFSDIE-QGZVFWFLSA-N 0.000 description 1
- HSRPVAXHWXFFMC-UHFFFAOYSA-N 4-[[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]-n,n-dimethylbenzamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 HSRPVAXHWXFFMC-UHFFFAOYSA-N 0.000 description 1
- FBZRJTBIWCSINF-UHFFFAOYSA-N 4-[[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]-n-ethylbenzamide Chemical compound C1=CC(C(=O)NCC)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 FBZRJTBIWCSINF-UHFFFAOYSA-N 0.000 description 1
- RLGDJANJVUKARK-UHFFFAOYSA-N 4-[[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 RLGDJANJVUKARK-UHFFFAOYSA-N 0.000 description 1
- KQMGETSFTKVPDP-UHFFFAOYSA-N 4-[[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CNC(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 KQMGETSFTKVPDP-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 0 CCC(C)(*)C(*)C*(*)OC(C*N(C*)**)*N(*)C(N(*)*)=O Chemical compound CCC(C)(*)C(*)C*(*)OC(C*N(C*)**)*N(*)C(N(*)*)=O 0.000 description 1
- QPJVMBTYPHYUOC-UHFFFAOYSA-N Methyl benzoate Natural products COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 1
- MASQFNVLASGXIM-UHFFFAOYSA-N N-[3-[[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=C1 MASQFNVLASGXIM-UHFFFAOYSA-N 0.000 description 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000006277 halobenzyl group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 125000000814 indol-3-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C([*])C2=C1[H] 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- CRMHHVVQZYELMA-UHFFFAOYSA-N methyl 2-[[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]methyl]-4-methyl-1,3-thiazole-5-carboxylate Chemical compound CC1=C(C(=O)OC)SC(CNC(=O)NCC2OCCN(CC=3C=C(Cl)C(Cl)=CC=3)C2)=N1 CRMHHVVQZYELMA-UHFFFAOYSA-N 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- HOIQLEVVPCJBOJ-UHFFFAOYSA-N n-[2-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methylcarbamoylamino]ethyl]acetamide Chemical compound C1COC(CNC(=O)NCCNC(=O)C)CN1CC1=CC=C(Cl)C(Cl)=C1 HOIQLEVVPCJBOJ-UHFFFAOYSA-N 0.000 description 1
- DAOQTVZWCWNOQY-FQEVSTJZSA-N n-[[(2s)-4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1C[C@H](CNC(=O)N2CC3=CC=CC=C3CCC2)OCC1 DAOQTVZWCWNOQY-FQEVSTJZSA-N 0.000 description 1
- LFHXYZFGXFIMCN-UHFFFAOYSA-N n-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-1,1-dioxo-1,4-thiazinane-4-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)N2CCS(=O)(=O)CC2)OCC1 LFHXYZFGXFIMCN-UHFFFAOYSA-N 0.000 description 1
- OJUZMUYMBSLEJF-UHFFFAOYSA-N n-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]-4-methylpiperidine-1-carboxamide Chemical compound C1CC(C)CCN1C(=O)NCC1OCCN(CC=2C=C(Cl)C(Cl)=CC=2)C1 OJUZMUYMBSLEJF-UHFFFAOYSA-N 0.000 description 1
- YGFCKXUIZVZIDV-UHFFFAOYSA-N n-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]morpholine-4-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)N2CCOCC2)OCC1 YGFCKXUIZVZIDV-UHFFFAOYSA-N 0.000 description 1
- WRORIWYXXPGIJG-UHFFFAOYSA-N n-[[4-[(3,4-dichlorophenyl)methyl]morpholin-2-yl]methyl]thiomorpholine-4-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CC(CNC(=O)N2CCSCC2)OCC1 WRORIWYXXPGIJG-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- RFIOZSIHFNEKFF-UHFFFAOYSA-M piperazine-1-carboxylate Chemical compound [O-]C(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-M 0.000 description 1
- DNUTZBZXLPWRJG-UHFFFAOYSA-M piperidine-1-carboxylate Chemical compound [O-]C(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-M 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0023973A GB0023973D0 (en) | 2000-09-29 | 2000-09-29 | Therapeutically useful compounds |
| GB0023973.1 | 2000-09-29 | ||
| GB0107643.9 | 2001-03-27 | ||
| GB0107643A GB0107643D0 (en) | 2001-03-27 | 2001-03-27 | Therapeutically useful compounds |
| PCT/GB2001/004350 WO2002026723A1 (en) | 2000-09-29 | 2001-09-28 | Compounds useful in the treatment of inflammatory diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004509953A JP2004509953A (ja) | 2004-04-02 |
| JP2004509953A5 true JP2004509953A5 (cg-RX-API-DMAC7.html) | 2008-11-13 |
| JP5069392B2 JP5069392B2 (ja) | 2012-11-07 |
Family
ID=26245081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002531107A Expired - Lifetime JP5069392B2 (ja) | 2000-09-29 | 2001-09-28 | 炎症性疾患の処置に有用な化合物 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7157457B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP1324991B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5069392B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20030040510A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1478084A (cg-RX-API-DMAC7.html) |
| AR (1) | AR037080A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE345331T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2001290146A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0114321A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2423305A1 (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ20031194A3 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60124576T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2275729T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0303107A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL155092A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA03002813A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20031443L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ525055A (cg-RX-API-DMAC7.html) |
| PL (1) | PL362984A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002026723A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0207450D0 (en) * | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
| US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| CZ2003353A3 (cs) | 2000-08-05 | 2003-05-14 | Glaxo Group Limited | Estery steroidních thiokyselin |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
| US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
| UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
| ES2314052T3 (es) | 2001-04-30 | 2009-03-16 | Glaxo Group Limited | Derivados de ester de 17beta-carbotioato de androstano con un grupo ester ciclico en la posicion 17alfa. |
| GB0207439D0 (en) * | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
| TW200400035A (en) * | 2002-03-28 | 2004-01-01 | Glaxo Group Ltd | Novel compounds |
| GB0207432D0 (en) | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
| GB0207436D0 (en) * | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
| GB0207449D0 (en) * | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
| GB0207447D0 (en) * | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
| GB0211759D0 (en) * | 2002-05-22 | 2002-07-03 | Glaxo Group Ltd | Novel compounds |
| GB0212357D0 (en) * | 2002-05-29 | 2002-07-10 | Glaxo Group Ltd | Novel compounds |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| AU2003275257A1 (en) | 2002-09-26 | 2004-04-19 | Bristol-Myers Squibb Company | N-substituted heterocyclic amines as modulators of chemokine receptor activity |
| ATE446951T1 (de) * | 2003-06-10 | 2009-11-15 | Biondi Ricardo Miguel | Verwendung einer verbingung gemäss formel i zur herstellung einer pharmazeutischen zubereitung |
| NZ545748A (en) | 2003-08-29 | 2010-03-26 | Ranbaxy Lab Ltd | Isoxazoline derivatives as inhibitors of phosphodiesterase type-IV |
| PL1801108T3 (pl) | 2004-09-08 | 2013-04-30 | Mitsubishi Tanabe Pharma Corp | Związki morfolinowe do leczenia stanów zapalnych |
| EP1992628A1 (en) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
| EP1958947A1 (en) | 2007-02-15 | 2008-08-20 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type 4 |
| AU2007349176A1 (en) * | 2007-03-13 | 2008-09-18 | Arete Therapeutics, Inc. | 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors |
| US8273766B2 (en) | 2007-04-04 | 2012-09-25 | Kowa Company, Ltd. | Tetrahydroisoquinoline compound |
| BRPI0820950A2 (pt) | 2007-12-05 | 2015-07-07 | Astrazeneca Ab | Composto, formulação farmacêutica, uso de um composto, métodos para o tratamento ou prevenção de condições ou doenças e para inibição da angiogênese, e, processo para a preparação de um composto. |
| US7851471B2 (en) | 2007-12-05 | 2010-12-14 | Astrazeneca Ab (Publ) | Compounds I |
| CN104203231A (zh) | 2011-12-01 | 2014-12-10 | 葛兰素集团有限公司 | 治疗和预防眼疾病的方法 |
| FR3022142B1 (fr) | 2014-06-16 | 2019-07-12 | Universite Paul Sabatier - Toulouse Iii | Inhibition de la chimiokine ccl7 ou de son recepteur ccr3 pour le traitement et le diagnostic du cancer de la prostate |
| CA2958800C (en) | 2014-08-22 | 2020-10-27 | Glaxosmithkline Intellectual Property Development Limited | Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection |
| WO2018134731A1 (en) | 2017-01-17 | 2018-07-26 | Glaxosmithkline Intellectual Property Development Limited | Non peptidic heterobivalent molecules for treating inflammatory diseases |
| TW202140550A (zh) | 2020-01-29 | 2021-11-01 | 瑞士商諾華公司 | 使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法 |
| CN111269340B (zh) * | 2020-03-31 | 2020-12-29 | 台州学院 | 一种以1-甲烷磺酰哌嗪为配体的螯合树脂及其制备方法和应用 |
| CN120132049B (zh) * | 2025-03-05 | 2025-08-26 | 西南医科大学附属口腔医院 | 茶多酚涂层改性的3d打印掺锶羟基磷灰石复合支架的制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3087763B2 (ja) * | 1990-11-30 | 2000-09-11 | 三井化学株式会社 | 新規な複素環式化合物およびそれを含有する医薬組成物 |
| JPH04247074A (ja) * | 1991-02-01 | 1992-09-03 | Yoshitomi Pharmaceut Ind Ltd | ４−モルホリノ安息香酸誘導体の製造法 |
| JPH04270272A (ja) * | 1991-02-25 | 1992-09-25 | Yoshitomi Pharmaceut Ind Ltd | アミノアルキルモルホリン誘導体の製造法 |
| EP0760362B1 (en) * | 1994-05-18 | 2002-08-14 | Nisshin Seifun Group Inc. | diaminomethylidene derivative |
| US5753654A (en) * | 1994-05-18 | 1998-05-19 | Nisshin Flour Milling Co., Ltd. | Diaminomethylidene derivatives |
| HU230154B1 (hu) * | 1997-11-12 | 2015-09-28 | Bayer Intellectual Property Gmbh | Eljárás 2-es helyzetben fenil-szubszituenst hordozó imidazo-triazinon-származékok előállítására |
| WO2000031032A1 (en) | 1998-11-20 | 2000-06-02 | F. Hoffmann-La Roche Ag | Pyrrolidine derivatives-ccr-3 receptor antagonists |
| CA2346933A1 (en) | 1998-12-18 | 2000-06-22 | Dupont Pharmaceuticals Company | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| CA2347769A1 (en) | 1998-12-18 | 2000-06-22 | Dean A. Wacker | 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity |
-
2001
- 2001-09-28 BR BR0114321-2A patent/BR0114321A/pt not_active IP Right Cessation
- 2001-09-28 IL IL15509201A patent/IL155092A0/xx unknown
- 2001-09-28 DE DE60124576T patent/DE60124576T2/de not_active Expired - Lifetime
- 2001-09-28 EP EP01970027A patent/EP1324991B1/en not_active Expired - Lifetime
- 2001-09-28 AR ARP010104603A patent/AR037080A1/es not_active Application Discontinuation
- 2001-09-28 KR KR10-2003-7004593A patent/KR20030040510A/ko not_active Withdrawn
- 2001-09-28 AU AU2001290146A patent/AU2001290146A1/en not_active Abandoned
- 2001-09-28 CN CNA018196489A patent/CN1478084A/zh active Pending
- 2001-09-28 AT AT01970027T patent/ATE345331T1/de not_active IP Right Cessation
- 2001-09-28 NZ NZ525055A patent/NZ525055A/en unknown
- 2001-09-28 US US10/381,871 patent/US7157457B2/en not_active Expired - Lifetime
- 2001-09-28 ES ES01970027T patent/ES2275729T3/es not_active Expired - Lifetime
- 2001-09-28 WO PCT/GB2001/004350 patent/WO2002026723A1/en not_active Ceased
- 2001-09-28 PL PL01362984A patent/PL362984A1/xx not_active Application Discontinuation
- 2001-09-28 HU HU0303107A patent/HUP0303107A2/hu unknown
- 2001-09-28 CZ CZ20031194A patent/CZ20031194A3/cs unknown
- 2001-09-28 EP EP05076503A patent/EP1586567A1/en not_active Withdrawn
- 2001-09-28 JP JP2002531107A patent/JP5069392B2/ja not_active Expired - Lifetime
- 2001-09-28 MX MXPA03002813A patent/MXPA03002813A/es unknown
- 2001-09-28 CA CA002423305A patent/CA2423305A1/en not_active Abandoned
-
2003
- 2003-03-28 NO NO20031443A patent/NO20031443L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004509953A5 (cg-RX-API-DMAC7.html) | ||
| JP2004509952A5 (cg-RX-API-DMAC7.html) | ||
| JP2002540204A5 (cg-RX-API-DMAC7.html) | ||
| JP2013506637A5 (cg-RX-API-DMAC7.html) | ||
| JP2009537543A5 (cg-RX-API-DMAC7.html) | ||
| JP2007516173A5 (cg-RX-API-DMAC7.html) | ||
| JP2002536445A5 (cg-RX-API-DMAC7.html) | ||
| JP2004517080A5 (cg-RX-API-DMAC7.html) | ||
| JP2013517283A5 (cg-RX-API-DMAC7.html) | ||
| CA2396824A1 (en) | Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 | |
| JP2009221205A5 (cg-RX-API-DMAC7.html) | ||
| WO2003000256A1 (de) | Kombinationstherapie substituierter oxazolidinone | |
| WO2008130021A2 (en) | Heterocyclic hydrazide compound and pesticidal use of the same | |
| RU2002132385A (ru) | Новые соединения | |
| EP1152759A2 (en) | METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR | |
| JP2002506858A (ja) | Ｃｍｖ感染症の治療に有用な１，３，４−チアジアゾール | |
| RU2008141510A (ru) | Новые соединения | |
| JP2008519761A5 (cg-RX-API-DMAC7.html) | ||
| JP2006503081A5 (cg-RX-API-DMAC7.html) | ||
| JP2004523490A5 (cg-RX-API-DMAC7.html) | ||
| RU2012117885A (ru) | 2,3,5-тризамещенные пирролы, фармацевтическая композиция и лекарственное средство (варианты) на их основе, способ получения соединений (варианты) | |
| RU2011116232A (ru) | Пиразолопиридиновые производные как ингибиторы надфн-оксидазы | |
| ZA200508623B (en) | Use of derivatives of 2,4-dihydro-[1,2,4]triazole-3-thione as inhibitors of the enzyme myeloperoxidase (MPO) | |
| JP2008502614A5 (cg-RX-API-DMAC7.html) | ||
| RU2006118686A (ru) | N-замещенные бензолсульфонамиды |